Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Phantom ActivCore Hindfoot Nail System Launches

Today Paragon® 28 announced the launch of Phantom ActivCore Hindfoot Nail System. The Precision® Guided ActivCore Nail addresses a TTC arthrodesis and is the second of four hindfoot fusion nailing systems Paragon 28 plans to launch in 2020.

Phantom ActivCore Hindfoot Nail System is constructed from Type II Anodized Titanium Alloy and has an outer sheath with a proximal Flex Coil tip and inner sliding core which allows for constant active compression. The Nail is designed to maintain compression across all joint surfaces and can compensate for up to 8 mm of bone resorption. The Nail accommodates two Ø7.2 mm fully threaded, headless calcaneal Pegs that are inserted from posterior to anterior at a variable (0-18°) angle. These Pegs provide fixation distally and work with the inner core, outer sheath, and Tibial Pegs to allow for active compression to pass through the joint surfaces.

The ActivCore system leverages PRECISION® Guide technology allowing for reproducibility when placing a Ø3.0 mm Drill-pin from distal to proximal, through the center of the calcaneus and up to the tibia. As with the previous Phantom® Hindfoot Nail System, all ActivCore Nails are engineered with a proximal Flex Coil design to provide flexibility as the implant finds its way through the contouring of the tibial canal. All Pegs are inserted from posterior to anterior and medial to lateral eliminating the need to take down the fibula.

The Phantom® ActivCore Nails will be offered in 22 size options with three diameters and four lengths. The distal diameter of all Nails is Ø13.3 mm with a transition to either Ø10.0, Ø11.5 or Ø13.0 mm above the ankle joint and 10.0mm at the Flex Coil tip. The distal diameter was increased at the joint spaces to add strength to the implant where it is needed most. The Phantom® ActivCore System will include a comprehensive offering of procedural instrumentation to address joint preparation and restoration of anatomic alignment.

The ActivCore Nail is implanted utilizing the carbon fiber Phantom® Ghost™ Outrigger. The radiolucent and inlay features of the Outrigger allow for visualization of Peg trajectory under fluoroscopy prior to drilling.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy